EFFECT OF ICODEXTRIN OR GLUCOSE PERITONEAL DIALYSIS (PD) SOLUTIONS ON TRIGLYCERIDE AND OLEIC ACID LEVELS IN PD PATIENTS (EXIT TRIAL)

被引：0
|
作者：
Lee, Sumi [1 ]
Jeong, Yu In [1 ]
Choi, DongHo [1 ]
Lee, Chungsik [2 ]
Son, Young Ki [1 ]
Kim, Seong Eun [1 ]
An, Won Suk [1 ]
机构：
[1] Dong A Univ Hosp, Dept Internal Med, Busan, South Korea
[2] Cheju Halla Hosp, Dept Internal Med, Jeju, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P1210
引用
收藏
页码：1535 / 1535
页数：1
相关论文
共 49 条
  • [21] USE OF A 1.1-PERCENT AMINO-ACID (AA) DIALYSIS SOLUTION TO TREAT MALNUTRITION IN PERITONEAL-DIALYSIS (PD) PATIENTS
    JONES, M
    HAGEN, T
    VONESH, E
    MORAN, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 580 - 580
  • [22] The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
    Johnson, David W.
    Brown, Fiona G.
    Clarke, Margaret
    Boudville, Neil
    Elias, Tony J.
    Foo, Marjorie W. Y.
    Jones, Bernard
    Kulkarni, Hemant
    Langham, Robyn
    Ranganathan, Dwarakanathan
    Schollum, John
    Suranyi, Michael G.
    Tan, Seng H.
    Voss, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (12) : 4445 - 4453
  • [23] Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial)
    Matsuoka, Naoko
    Nakazawa, Daigo
    Nishio, Saori
    Cho, Kyu Yong
    Maoka, Tomochika
    Kaneshima, Nobuharu
    Yamamoto, Rie
    Yamamoto, Junya
    Shimamoto, Mamiko
    Makita, Minoru
    Iriuda, Satoko
    Igarashi, Kento
    Ito, Yosuke
    Kato, Akiko
    Yoshikawa, Junpei
    Kudo, Takashi
    Nagashima, Takahiro
    Ito, Yoichi M.
    Atsumi, Tatsuya
    BMJ OPEN, 2024, 14 (11):
  • [24] Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients:: their relationship with nutritional parameters
    Aguilera, A
    Codoceo, R
    Selgas, R
    Garcia, P
    Picornell, M
    Diaz, C
    Sanchez, C
    Bajo, MA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (06) : 1476 - 1483
  • [25] Acute changes in plasma ghrelin levels after oral feeding are blunted in uremic patients undergoing chronic peritoneal dialysis (PD)
    Rodríguez-Carmona, A
    Pérez-Fontán, M
    Cordido, F
    Villaverde, P
    García-Buela, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V135 - V135
  • [26] FALSE ELEVATION OF BLOOD GLUCOSE LEVELS MEASURED BY GDH-PQQ-BASED GLUCOMETERS OCCURS DURING ALL DAILY DWELLS IN PERITONEAL DIALYSIS PATIENTS USING ICODEXTRIN
    Tsai, Chiu-Yeh
    Lee, Su-Chu
    Hung, Chi-Chih
    Lee, Jia-Jung
    Kuo, Mei-Chuan
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    PERITONEAL DIALYSIS INTERNATIONAL, 2010, 30 (03): : 329 - 335
  • [27] Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients
    An, W. S.
    Lee, S. M.
    Son, Y. K.
    Kim, S. E.
    Kim, K. H.
    Han, J. Y.
    Bae, H. R.
    Park, Y.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2012, 86 (1-2): : 29 - 34
  • [28] Vitamin B12 and holotranscobalamin levels in patients with end stage renal disease (ESRD), hemo (HD) or peritoneal dialysis (PD)
    De Vecchi, Amedeo F.
    Novembrino, Cristina
    Bamonti, Fabrizia
    Lonati, Silvia
    Cerutti, Roberta
    Guerra, Luisella
    Messa, Piergiorgio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 341 - 341
  • [29] IS THERE A DAY-OF-WEEK EFFECT ON MORTALITY, OCCURRENCE OF PERITONITIS AND TRANSFER TO HEMODIALYSIS (HD) IN FRENCH AND BELGIAN PATIENTS ON PERITONEAL DIALYSIS (PD)?
    Dratwa, Max
    Collart, Frederic
    Verger, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 221 - 222
  • [30] A retrospective examination of the effect of IV zemplar(Z) on iPTH in peritoneal dialysis(PD) patients resistant to oral vitamin D.
    Shirley, L
    Sheleheda, D
    Robirds, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 394A - 394A
12345